In male mice with prostate epithelium-specific Pten-knockout mouse prostate cancer model, low dose of rapamycin (formulated as Rapatar) was effective in suppressing proliferation of prostate epithelial cells and prevention of prostate cancer. This evidence concerns the gene PTEN and prostate cancer.